RE: Yesterday Businees weekly interview21 Sep 2021 15:02
A further trial will be take place and hopefully the outcome will be a drug – a simple oral tablet – that will benefit diabetic patients who contract Covid-19. It is a very exciting prospect.
We are extremely grateful that a swathe of investors including Mohamed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi, the Mubadala Sovereign Wealth Fund, the UK Government and Chlodwig Enterprises, an international ESG life sciences investment company, supported this important trial.